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Background: To assess the effect of implantoplasty and implant-abutment design on the fracture resistance and 
macroscopic morphology of narrow-diameter (3.5 mm) dental implants.
Material and Methods: Screw-shaped titanium dental implants (n = 48) were studied in vitro. Three groups (n = 
16) were established, based on implant-abutment connection type: external hexagon, internal hexagon and coni-
cal. Eight implants from each group were subjected to an implantoplasty procedure; the remaining 8 implants 
served as controls. Implant wall thickness was recorded. All samples were subjected to a static strength test.
Results: The mean wall thickness reductions varied between 106.46 and 153.75 µm. The mean fracture strengths 
for the control and test groups were, respectively, 1211.90±89.95 N and 873.11±92.37 N in the external hexa-
gon implants; 918.41±97.19 N and 661.29±58.03 N in the internal hexagon implants; and 1058.67±114.05 N and 
747.32±90.05 N in the conical connection implants. Implant wall thickness and fracture resistance (P < 0.001) 
showed a positive correlation. Fracture strength was influenced by both implantoplasty (P < 0.001) and connection 
type (P < 0.001).
Conclusions: Implantoplasty in diameter-reduced implants decreases implant wall thickness and fracture resis-
tance, and varies depending on the implant-abutment connection. Internal hexagon and conical connection im-
plants seem to be more prone to fracture after implantoplasty.
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Introduction
Over recent decades, oral rehabilitation with dental im-
plants has shown highly satisfactory results regarding 
restoration of the patient’s function and esthetics, with 
predictable and safe long-term results (1,2). However, 
both short- and long-term complications may arise (3). 
In particular, peri-implantitis is becoming a more com-
mon condition, reaching a frequency close to 20% when 
determined at the patient level (4). Peri-implantitis is 
defined as a chronic inflammatory disease of an infec-
tious nature characterized by peri-implant soft tissue 
inflammation in combination with radiographic bone 
loss (5). The main risk indicators associated with peri-
implantitis are a history of chronic periodontitis, smok-
ing, poor plaque control, and no regular maintenance 
care after implant therapy (6,7).
Different protocols have been suggested in the treat-
ment of peri-implantitis. As non-surgical procedures 
alone appear to be insufficient to resolve these lesions, 
additional surgical treatment by means of open flap de-
bridement combined with augmentative and/or resec-
tive approaches seems to be necessary (8).
Implantoplasty (IP) has been proposed as a procedure 
to smoothen and polish endosseous implant parts pass-
ing the bony envelope (9). The purpose of IP is firstly 
to remove the infected layer of titanium and secondly 
to produce a less plaque-retentive surface by reducing 
its roughness (10). Several case series and clinical trials 
have demonstrated a beneficial effect of IP when it is 
included as part of a resective surgical approach (11,12) 
or a combined resective and regenerative strategy (13-
15). Nevertheless, IP reduces the implant diameter and 
the thickness of the implant wall and, together with the 
bone loss from peri-implantitis, may increase the risk of 
fixture fracture (16-18).
Both the diameter and type of implant-abutment con-
nection design determine the thickness of the implant 
wall. Accordingly, the impact of IP on the mechanical 
properties could be greater in implants with a thinner 
wall. An in vitro study comparing standard (3.75 mm) 
and wide diameter implants (4.7 mm) concluded that 
IP reduced the strength of standard implants, but no 
changes occurred in wide fixtures (19). Similarly, Geh-
rke et al. (20) compared three different implant connec-
tions and found that the resistance to loading of 4 mm 
diameter implants decreased significantly after IP but 
varied among the three implant-abutment designs, the 
Morse tapered fixtures being the most resistant. Howev-
er, none of these studies were conducted under the most 
unfavorable conditions (i.e. ≤3.5 mm diameter implants 
with a bone loss equivalent to 50% of their length). 
Therefore, the aim of the present study was to assess 
whether IP and implant-abutment design influence the 
fracture resistance of narrow-diameter, screw-shaped, 
rough-surfaced titanium dental implants in conjunction 
with a horizontal peri-implant defect corresponding to 
half of their length. The secondary objectives were to 
time the IP procedure and to assess the morphological 
changes that occurred in the treated areas.
Material and Methods
An in vitro study was conducted using 48 tapered tita-
nium grade 5 dental implants with similar macroscopic 
and microscopic designs (Biomimetic Ocean®, Avi-
nent® Implant System, Santpedor, Spain). Three differ-
ent implant-abutment connection designs were used for 
a total of 16 fixtures in each group: external hexagonal 
connection (EC), internal hexagonal connection (IC) 
and conical connection (CC). The platform and body di-
ameters of the implants were 3.5 mm and the total body 
length was 10 mm. The implant threads were V-shaped 
and measured 0.08 and 0.28 mm in depth at the neck 
and body of the fixture, respectively.
The surface was moderately rough as a result of the 
sandblasting, acid-etching and anodizing techniques.
Using a computer generated random sequence, 8 implants 
per group received IP on the coronal half, and the remain-
ing 8 served as controls in the fracture resistance tests.
- Cast preparation
All the implants were embedded and placed in exactly 
the same position in 3x1.7 cm epoxy resin casts (EA 
3471 A and B Loctite®, Henkel AG & Company, Düs-
seldorf, Germany) with a Young’s modulus of elastic-
ity (≥3GPa), in such a way that 5 mm of rough surface 
was exposed. This simulated a horizontal supracrestal 
peri-implant defect of 5 mm (50% of the total implant 
length), which is 2 mm more than the International 
Standardization Organization (ISO) guidelines.
- IP procedure
A cover screw was inserted to protect the implant’s con-
nection from titanium debris. IP was performed manual-
ly by an experienced clinician (O.C-F.) using a handheld 
high-speed handpiece (GENTLEsilence LUX 8000B, 
KaVo® Dental GmbH, Biberach an der Riß, Germany) 
with abundant water cooling, under 2.8x magnifica-
tion loupes with a LED light (Galilean HD and Focus™ 
LED 6000k, ExamVision ApS, Samsø, Denmark), and 
with adequate illumination in an environment similar to 
the dental setting. The pressure applied and number of 
strokes were not standardized to increase the external 
validity of the study. The operator’s other hand held and 
turned the cast.
The simplified 3-bur protocol described by Costa-
Berenguer et al. (21) was followed. After removing 
the threads of the coronal half of the implants using 
an oval-shaped tungsten carbide bur (H379.314.023 
Komet, GmbH & Co. KG, Lemgo, Germany), the sur-
face was sequentially polished with two silicon car-
bide polishers (9618.314.030 and 9608.314.030 Komet, 
GmbH & Co. KG, Lemgo, Germany) until the operator 
e693
Med Oral Patol Oral Cir Bucal. 2020 Sep 1;25 (5):e691-9. Fracture resistance after implantoplasty
felt that the exposed threads and structured areas were 
adequately smoothed. An external examiner (A.G-B.) 
registered the time employed with each bur. A new set 
of burs was used for each implant. Finally, the cover 
screw was removed.
- Macroscopic changes in implants
Periapical radiographs of all the implants were taken 
with a standardized long-cone paralleling technique. 
The digital images were used to assess the average 
thickness of the left and right implant walls at the im-
plant shoulder (T0) and at 2.5 mm (T2.5) and 5 mm (T5) 
in an apical direction. The IP group measurements were 
subtracted from those of their control analogues to ob-
tain the wall thinning calculation for each point. The 
six measurements were then repeated after turning the 
implant 120º and 240º, leading to a total of 18 measure-
ments for each implant. This procedure was performed 
by the same trained examiner (A.G-B.) using Image-
JTM software (National Institutes of Health, Bethesda, 
Maryland, USA). To test intraexaminer agreement and 
consistency, the assessment of 15 randomly selected 
radiographs (90 measurements) was repeated after 2 
weeks. The intraclass correlation coefficients (ICC) 
were 0.97 (95% confidence interval (95%CI) 0.94 to 
0.99; p<0.001) and 0.98 (95%CI 0.96 to 0.99); P<0.001), 
showing excellent reliability and consistency.
- Static strength test
All the implants (n = 48) were subjected to a static com-
pressive force. The tests were performed according to 
the specifications of the ISO 14801:2016 guideline, ex-
cept for the defect size.
Identical metal hemispherical load abutments (n = 48) 
were digitally designed, milled and placed on each 
implant. After applying a 32 N·Cm torque, prosthetic 
screws (Avinent® Implant System, Santpedor, Spain) 
were used to retain the load abutments.
All the tests were performed at a constant speed of 1 
mm/min with a MTS Bionix 370 Load Frame universal 
servo-hydraulic mechanical testing machine (MTS®, 
Eden Prairie, USA), applying a compression force to 
the implants with a MTS Load Cell 661.19H-03 of 15kN 
capacity. All the samples were held with the same de-
vice, a manufactured stainless-steel clamping jaw that 
allowed compression forces to be applied at a constant 
angle of 30º from the vertical axis. The tests were con-
trolled with TestStar II® software (MTS®, Eden Prairie, 
USA), which recorded real-time data from the 48 sam-
ples. The maximum compression force (Fmax) was mea-
sured as the maximum force reached until the sample 
fractured or exhibited a significant amount of plastic 
deformation and a load drop before implant fracture.
- Surface evaluation and fractographic analysis
All samples were assessed by scanning electron micros-
copy (SEM; Quanta-200, Field Electron and Ion Com-
pany, Hillsboro, USA) to determine their surface quality 
semi-quantitatively, as well as the presence of impuri-
ties, fractures, deformation, scuffing, cracks, or fissures. 
Images of the fractured components were also taken.
- Statistical analysis
The sample size calculation was based on results re-
ported by Gehrke et al. (20) Considering Fmax as the pri-
mary outcome measure, the expected mean reductions 
in fracture resistance after IP were 286 N, 333.7 N and 
180.5 N in the EC, IC and CC groups, respectively, with 
a common standard deviation of 100 N. Under these 
assumptions, 8 implants per group were required (two-
way analysis of variance (ANOVA), α = 0.05 and 1-β = 
0.80).
The implant characteristics were presented as abso-
lute and relative frequencies for categorical outcomes. 
Normality of scale variables (Fmax and implant wall 
thickness) were explored through Shapiro-Wilk’s test 
and visual analysis of the P-P and box plots. Where 
normality was rejected, the interquartile range (IQR) 
and median were calculated. Where the distribution 
was compatible with normality, the mean and standard 
deviation (SD) were used.
To analyze the effect of the procedure (IP or con-
trol), implant-abutment design (EC, IC or CC) and 
the interaction between these two variables on Fmax, 
a two-way ANOVA was performed. Fulfillment of the 
assumptions was ensured through tests of normality 
and homogeneity of variances (i.e. Shapiro-Wilk’s and 
Levene’s tests, respectively). For each procedure and 
implant-abutment design, pairwise comparisons be-
tween groups were performed.
An unpaired t test was used to identify differences 
in implant wall thickness between the control and IP 
groups at every reference point. Differences in thick-
ness between the implant-abutment designs at each of 
the 3 reference points were assessed by means of a one-
way ANOVA. For each area of interest, Pearson correla-
tion coefficients were computed to quantify the correla-
tion between the implant wall thickness and Fmax.
The association of categorical variables was assessed 
with either Pearson’s χ2 test or Fisher’s exact test.
The statistical analysis was carried out with Stata14 
(StataCorp®, College Station, TX, USA). The level of 
significance was set at P < 0.05, using Tukey’s correc-
tion for multiplicity of contrasts.
Results
All samples were treated without registering any devia-
tion from the protocol.
- Treatment time
The mean time used with the carbide burs was 5 min 32 
s (SD = 35 s), and the two silicon carbide polishers were 
employed for mean times of 2 min 41 s (SD = 20 s) and 
2 min 25 s (SD = 26 s), respectively. The total IP mean 
time per implant was 10 min 37 s (SD = 55 s).
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T2.5 (r = 0.75; n = 48; P < 0.001) and T5 (r = 0.61; n = 
48; P < 0.001) (Fig. 1).
Perforations of the implant wall were not observed.
- Static strength test
Compression tests revealed that IP produced a signifi-
cant reduction in fracture resistance (F[1, 42]=130.31, P 
< 0.001). Specifically, the EC, IC and CC groups expe-
rienced a Fmax decrease of 27.96%, 28.00% and 29.41%, 
respectively (Table 2).
- Macroscopic changes to implants
The mean reductions in implant wall thickness after IP 
are summarized in Table 1. In all groups, the procedure 
was associated with a statistically significant reduction in 
thickness (P ≤ 0.05; unpaired t test) at T0-5. The amount 
of change was similar in all the implant-abutment designs 
at each reference point (all P > 0.05; one-way ANOVA).
There was a positive correlation between implant wall 
thickness and Fmax at T0 (r = 0.55; n = 48; P < 0.001), 
Table 1: Mean implant wall thickness (µm) in IP and control samples at each reference point (n=48).
Control IP
Reference 






EC 934.38 (45.95) 800.83 (51.25) 133.54 (81.35 to 185.73) <0.001*
0.687IC 593.75 (96.30) 472.92 (66.33) 120.83 (32.17 to 209.50) 0.011*
CC 438.96 (29.24) 329.79 (48.57) 109.17 (66.18 to 152.16) <0.001*
T2.5 mm
EC 891.46 (50.08) 779.38 (57.04) 112.08 (54.52 to 169.65) 0.001*
0.090IC 558.33 (32.97) 404.58 (35.06) 153.75 (117.25 to 190.25) <0.001*
CC 644.17 (36.59) 508.75 (17.01) 135.42 (104.62 to 166.02) <0.001*
T5 mm
EC 943.13 (44.22) 809.58 (55.02) 133.54 (80.02 to 187.07) <0.001*
0.625IC 867.08 (32.24) 760.63 (48.31) 106.46 (61.42 to 150.50) <0.001*
CC 1000.63 (75.84) 870.83 (32.64) 129.79 (67.18 to 192.40) 0.001*
*Statistically significant difference; IP: implantoplasty; MD: Mean difference (Control - IP); EC: external connection; IC: internal connection; 
CC: conical connection.
Control IP
Connection Mean (SD) Mean (SD) MD (95%CI) P-value
EC 1211.90 (89.85) 873.11 (92.37) 338.79 (246.19 to 431.39) <0.001*
IC 918.41 (97.19) 661.29 (58.03) 257.12 (164.52 to 349.73) <0.001*
CC 1058.67 (114.05) 747.32 (90.05) 311.35 (218.74 to 403.95) <0.001*
*Statistically significant difference; IP: implantoplasty; MD: Mean difference (Control - IP); EC: external connection; IC: internal connection; 
CC: conical connection.
Fig. 1: Scattergrams with a 95%CI showing the correlation between coronal (a), middle (b) and apical (c) implant wall thickness and fracture resistance.
Table 2: Mean fracture strength (N) of the three implant-abutment designs in IP and control samples.
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Fmax was also influenced by the implant connection de-
sign (F[2, 42)]= 30.43, P < 0.001). In both the control 
and IP samples, the EC implants were more resistant 
than the IC [(MDcontrol = 293.49 N; 95%CIcontrol = 182.00 
to 404.97; t[42]control = 6.40; Pcontrol < 0.001) (MDIP = 
211.82 N; 95%CIIP = 100.34 to 323.30; t[42]IP = 4.62; PIP 
< 0.001)] and CC [(MDcontrol = 153.23 N; 95%CIcontrol = 
41.75 to 264.71; t[42]control = 3.34; Pcontrol = 0.005) (MDIP 
= 125.79 N; 95%CIIP = 33.18 to 218.39; t[42]IP = 2.74; PIP 
= 0.024)] fixtures. Among the control samples, the CC 
implants withstood significantly higher compression 
forces than the IC ones (MD = 140.26 N; 95%CI = 28.74 
to 251.74; t[42] = 3.06; P = 0.012) (Table 3). However, 
the results for both CC and IC implants were similar 
after IP (Table 3).
The effect of interaction between implant-abutment de-
sign and procedure was not significant (F[2, 42] = 0.82, 
P = 0.447).
- Surface evaluation and fractographic analysis
SEM analysis of the control implants showed a good 
quality surface finish, free of fissures, and/or defects 
from the machining process. The surface was moder-
ately rough as a result of the sandblasting, acid-etching 
and anodizing techniques (Fig. 2).
IP samples showed a smooth surface, free of grooves. Tita-
nium shavings were identified in the areas of interest. Sili-
con debris was also found in some of the samples (Fig. 2).
Two fracture patterns were identified: 1) perpendicular 
to the longitudinal axis of the implant, with fracture of 
the implant platform or body (Fig. 3), and 2) through the 
implant-abutment connection with fracture of the abut-
ment screw (Fig. 3).
Overall, 20 control specimens (83.3%) fractured through 
the abutment screw, while 16 IP samples (66.7%) frac-
tured through the implant (χ2[1] = 12.34; P < 0.001). 
Deformation at the edge of the implant platform on the 
opposite side to the application of force was observed in 
89.6% (n = 43) of cases.
SEM analysis of the implant fractures showed that the 
breakage was located where the threads and the implant 
body had the lowest cross-sectional thickness. These 
were ductile fractures with plastic deformation.
The fracture pattern recorded for each implant connec-
tion design is described in Table 4.
Group Con1 Con2 MD (95%CI) P-value
Control
EC
IC 293.49 (182.00 to 404.97) <0.000*
CC 153.23 (41.75 to 264.71) 0.005*
CC IC 140.26 (28.74 to 251.74) 0.011*
IP
EC
IC 211.82 (100.34 to 323.30) <0.001*
CC 125.79 (14.30 to 237.27) 0.024*
CC IC 86.03 (-25.45 to 197.51) 0.159
*Statistically significant difference; IP: implantoplasty; MD: Mean difference (Con1 - Con2); Con1 and Con2: Implant-




Control 8 (100%) platform deformation + abutment screw fracture
IP 3 (37.5%) platform deformation + abutment screw fracture5 (62.5%) implant body rupture
IC
Control 4 (50%) platform deformation + cervical rupture + implant body and abutment folding4 (50%) platform deformation + abutment screw fracture
IP 8 (100%) platform deformation + cervical rupture + implant body and abutment folding
CC
Control 8 (100%) platform deformation + abutment screw fracture
IP 4 (50%) platform deformation + cervical rupture + implant body and abutment folding4 (50%) platform deformation + abutment screw fracture
IP: implantoplasty; EC: external connection; IC: internal connection; CC: conical connection.
Table 3: Differences in mean fracture strength (N) of the IP and control samples for the three implant-abutment connections.
Table 4: Fractographic analysis by implant abutment-design (n=48).
e696
Med Oral Patol Oral Cir Bucal. 2020 Sep 1;25 (5):e691-9. Fracture resistance after implantoplasty
Discussion
The present in vitro study aimed to describe and an-
alyze the inf luence of a specific IP protocol on the 
fracture resistance and wall thickness of narrow-di-
ameter implants in three implant-abutment designs.
Marginal bone loss associated with peri-implan-
titis usually extends to the level corresponding to 
the end of the internal chamber of the abutment 
screw, where resistance to bending is diminished 
(18,22,23). Gehrke et al. (17) reported average re-
ductions in strength of 37.2% and 53.8% when the 
level of cervical insertion was located 3 mm and 5 
mm below the implant shoulder, respectively. Con-
sequently, the samples in the present study were 
manufactured to simulate a horizontal peri-implant 
defect of 5 mm (50% of the total implant length) in 
order to recreate a common but mechanically unfa-
vorable situation (18).
Fig. 2: Scanning electron microscopy (SEM) macrographs of a control (a) and a test (b) implant. Detail of a control implant surface 
at 200 × (c) and 1500 × (d) magnification with SEM. Detail of a test implant polished surface without any debris at 200 × (e) and 1500 
× (f) magnification with SEM. Detail at 200 × magnification of the interface between the polished and untreated portion of a test 
implant (g). Detail at 800 × magnification of silicon debris found on the polished area of a test implant (h).
Fig. 3: (a) Control EC implant fractured at the implant-abutment connection; (b) Test EC implant fractured through the body; (c, 
d) Control and test IC implants fractured in the cervical area; (e, f) Control and test CC implants fractured at the implant-abutment 
connection.
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Although a recent investigation using EC standard-
diameter implants concluded that IP does not seem to 
decrease the fracture strength (21), others have revealed 
a weakening of the fixture when IP is performed (18-
20). The latter is in accordance with the present obser-
vations, where IP produced an almost 30% decrease in 
fracture resistance (F[1, 42] = 130.31, P < 0.001) (Table 
2). This weakening also implied a change in the frac-
ture pattern, since, while 20 of the 24 control specimens 
(83.33%) fractured through the abutment screw, the 
rupture site of the majority of the test samples (n = 16; 
66.67%) was in the platform or body (χ2[1] = 12.34; P < 
0.001). This suggests that a certain implant wall thick-
ness is required in order to resist bending forces (19).
Fracture resistance was also influenced by implant 
abutment-design (F[2, 42] = 30.43, P < 0.001) (Table 3). 
Basically, it was observed that in both the control and 
the IP samples, the EC implants were the least prone to 
fractures whereas the IC implants were the most sus-
ceptible to rupture. Conversely, Gehrke et al. (20) found 
that Morse tapered fixtures presented significantly 
greater resistance than EC and IC ones. Differences in 
the IP protocol applied (mechanical lathe machine vs. 
manual simplified 3-bur protocol), and the implant di-
mensions used (4x11 mm vs. 3.5x10 mm), as well as the 
macroscopic design of the fixtures, may explain these 
conflicting results. Hence, future studies should be per-
formed with implant designs and IP protocols differ-
ing from the aforementioned in order to generalize the 
present results. In addition, considering that mastica-
tory forces are cyclic, dynamic fatigue tests should be 
carried out to predict how long the implants will func-
tion properly.
In accordance with ISO 14801:2016, the smallest 
diameter implant was used in order to simulate the 
most unfavorable clinical scenario. In this context, to 
the best of the authors’ knowledge, the present report 
is the first that assesses the effect of IP on narrow-di-
ameter implants. Previous in vitro studies and finite 
element analyses have illustrated that stress values 
affecting the crestal cortical bone are reciprocal to 
the dental implant diameter, thus resulting in disad-
vantageous stress peaks at the implant-bone interface 
and a higher risk of fatigue fracture (24). The average 
maximum bite force for adults in the posterior regions 
is 847 N for men and 597 N for women (25). In the 
present study, the fracture strengths after static load-
ing of the control specimens were above these thresh-
olds (Table 2). However, when IP was performed, all 
three groups showed Fmax values close to those mas-
ticatory forces (Table 2). Accordingly, the clinician 
should be cautious when applying this procedure to 
narrow-diameter implants, especially those with an 
internal connection, at least until human studies shed 
some light on this topic.
Generally, implant strength is derived from the thick-
ness of the implant wall (19,26,27), which, in turn, is 
determined by the implant-abutment connection de-
sign. For this reason, we decided not to use the thick-
ness of the implant wall as a possible confounding fac-
tor due to the existence of collinearity between the two 
variables and the difficulty of measuring the actual re-
duction of the implant wall clinically. The present re-
sults agree with previous publications, since a statisti-
cally significant positive correlation with implant wall 
thickness was found at each of the reference points as-
sessed (Fig. 1). It should be noted that the walls of the 
IC and CC implants at T0 and T2.5 were almost half 
the width of the walls of the EC implants (Table 1). As 
a result, the EC implants had significantly higher Fmax 
values than the IC and CC implants in both the control 
and the IP samples. Indeed, the mean Fmax values ob-
tained in the EC group after IP were similar to those 
observed in the control IC implants. In addition, the 
thickness of the wall was also related to the fracture 
pattern, since implant rupture occurred in the portion 
where the wall was thinnest.
As any in vitro study, a possible limitation of the pres-
ent report is that IP was performed under ideal condi-
tions. In an environment closer to a real clinical situa-
tion, the results could differ from those obtained in this 
study. Another potential drawback is related to the fact 
that IP was performed manually. This leads to a lack 
of standardization of important variables like pressure 
and number of times that the burs were applied to the 
implant surface (21). On the other hand, this procedure 
is more similar to a real clinical scenario, and therefore 
increases the external validity of the study.
The simplified 3-bur IP protocol employing an average 
of 11 min (SD = 1) was able to produce a minimal im-
plant diameter reduction, restricted to the threads and 
without affecting the internal diameter of the speci-
mens. These outcomes were not influenced by the im-
plant connection design (Table 1). In this context, it 
must be emphasized that a potential drawback of the 
present study was the lack of further analyses to evalu-
ate the surface roughness of the smoothed implants. 
However, a recent report employing the same IP proto-
col has shown a mean Sa value of 0.1 µm (SD = 0.02), 
which is significantly lower than the 0.76 µm (SD = 
0.08) of the untreated controls (24). Similarly, Ramel et 
al. (10) obtained an effective smoothening of the surface 
through an IP procedure combining 3 diamond burs and 
2 silicone polishers which took 21 minutes (SD = 4) per 
implant. Nevertheless, the method they applied resulted 
in an average Ra value of 0.32 µm (SD = 0.14), which is 
higher than the Ra threshold (< 0.2 µm) beyond which 
bacterial adhesion cannot be further reduced (28-30). 
Future research should determine the most efficient, ef-
fective and safest IP procedure.
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Conclusions
Implantoplasty in diameter-reduced implants produc-
es a decrease in fracture resistance in all the narrow-
diameter titanium dental implant groups tested. The 
implant-abutment connection design influences the 
resistance of the fixture. Clinicians should be aware 
that implantoplasty might increase the risk of fracture, 
especially in narrow-diameter internal connection im-
plants (CC and IC).
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